Maneesh Pharmaceuticals Ltd — Rifampicin Exporter Profile
Indian Pharmaceutical Exporter · #7 for Rifampicin · $850.0K export value · DGFT Verified
Maneesh Pharmaceuticals Ltd is the #7 Indian exporter of Rifampicin with $850.0K in export value and 17 verified shipments. Maneesh Pharmaceuticals Ltd holds a 0.4% market share in Rifampicin exports across 7 countries.
Maneesh Pharmaceuticals Ltd — Rifampicin Export Profile: Buyers & Destinations
Where Does Maneesh Pharmaceuticals Ltd Export Rifampicin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SUDAN | $643.1K | 13 | 10.7% |
| PHILIPPINES | $462.4K | 19 | 7.7% |
| KENYA | $449.8K | 17 | 7.5% |
| INDONESIA | $405.4K | 17 | 6.8% |
| AFGHANISTAN | $400.0K | 8 | 6.7% |
| CONGO | $353.7K | 12 | 5.9% |
| NAMBIA | $309.0K | 8 | 5.2% |
| ANGOLA | $263.5K | 8 | 4.4% |
| NETHERLANDS | $233.1K | 20 | 3.9% |
| BURUNDI | $200.0K | 6 | 3.3% |
Maneesh Pharmaceuticals Ltd exports Rifampicin to 44 countries. The largest destination is SUDAN accounting for 10.7% of Maneesh Pharmaceuticals Ltd's Rifampicin shipments, followed by PHILIPPINES (7.7%) and KENYA (7.5%). These destinations reflect Maneesh Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Rifampicin from Maneesh Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AMBICA INTERNATIONAL CORPORATION | PHILIPPINES | $462.4K | 19 |
| SEKRETARIAT DITJEN PENCEGAHAN DAN P | INDONESIA | $400.0K | 8 |
| UNOCA COMPOUND JALALABAD ROAD KABUL | AFGHANISTAN | $250.0K | 5 |
| COUNTRY OFFICE CO BURUNDI | BURUNDI | $200.0K | 4 |
| FEDERAL MINISTRY OF HEALTH | SUDAN | $200.0K | 4 |
| REPUBLIQUE DU CONGO PROGRAMME DES NATIONS UNIESPOUR LE | CONGO | $200.0K | 4 |
| FEDERAL MINISTRY OF HEALTH DIRECTORATE OF INTERNATIONAL HEALTHGRANTS | SUDAN | $200.0K | 4 |
| COSPHARM INV T/A M PLUS PHARMACEUTI | NAMBIA | $196.5K | 4 |
| UNDP SOUTH SUDAN | SUDAN | $193.1K | 4 |
| 5 KAMPALA | KENYA | $179.9K | 4 |
Maneesh Pharmaceuticals Ltd supplies Rifampicin to 74 buyers globally. The largest buyer is AMBICA INTERNATIONAL CORPORATION (PHILIPPINES), followed by SEKRETARIAT DITJEN PENCEGAHAN DAN P (INDONESIA) and UNOCA COMPOUND JALALABAD ROAD KABUL (AFGHANISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Rifampicin Export Value and How Much Does Maneesh Pharmaceuticals Ltd Contribute?
India exported $121.8M worth of Rifampicin through 3,913 shipments from 175 suppliers to 162 countries, serving 780 buyers globally. Maneesh Pharmaceuticals Ltd contributes $850.0K to this total, accounting for 0.4% of India's Rifampicin exports. Maneesh Pharmaceuticals Ltd ships Rifampicin to 44 countries through 74 buyers.
What Is the Average Shipment Value for Maneesh Pharmaceuticals Ltd's Rifampicin Exports?
Maneesh Pharmaceuticals Ltd's average Rifampicin shipment value is $50.0K per consignment, based on 17 shipments totaling $850.0K. The largest destination is SUDAN (10.7% of Maneesh Pharmaceuticals Ltd's Rifampicin exports).
How Does Maneesh Pharmaceuticals Ltd Compare to Other Indian Rifampicin Exporters?
Maneesh Pharmaceuticals Ltd ranks #7 among 175 Indian Rifampicin exporters with a 0.4% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($64.0M), MACLEODS PHARMACEUTICALS LIMITED ($18.5M), LUPIN LIMITED ($18.4M). Maneesh Pharmaceuticals Ltd processed 17 shipments to 7 destination countries.
What Rifampicin Formulations Does Maneesh Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| RIFAMPICIN 150MG / ISONIAZID 75MG / PYRA | $672.9K | 29 |
| RIFAMPICIN 150MG / ISONIAZID 75MG TABS E | $341.6K | 18 |
| RIFAMPICIN 150MG / ISONIAZID 75MG TABS EACH CARTON OF 24X28 TABS | $293.3K | 8 |
| RIFAMPICIN 150MG / ISONIAZID 75MG TABS EACH CARTON OF 24X28 TABS 5280 CARTONS | $150.0K | 3 |
| RIFAMPICIN 150MG / ISONIAZID 75MG / PYRAZINAMIDE 400MG /ETHAMBUTOL 275MG TABS EACH CARTON OF 24X28 TABS 2690 CARTONS | $150.0K | 3 |
| 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ISONIAZID 75 MG/PYRAZINAMIDE 400MG/ETHAMBUTOL HCL 275MG TABLETS(25602 CNOS | $150.0K | 3 |
| 12 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ ISONIAZID 75 MG TABLETS (25602 CARTONS)NOS | $150.0K | 3 |
| RIFAMPICIN 150MG / ISONIAZID 75MG TABS EACH CARTON OF 24x28 TABS | $145.6K | 3 |
| PHARMA : RIFAMPICIN 150MG + ISONIAZID 75 | $143.1K | 3 |
| RIFAMPICIN 150MG/ISONIAZID 75MG/PYRAZINA | $106.3K | 3 |
Maneesh Pharmaceuticals Ltd exports 121 distinct Rifampicin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RIFAMPICIN 150MG / ISONIAZID 75MG / PYRA with 29 shipments worth $672.9K.
How Does Maneesh Pharmaceuticals Ltd Compare to Nearest Rifampicin Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | SANDOZ PRIVATE LIMITED | $1.5M | 57 | 11 | $27.1K |
| 6 | OMNICALS PHARMA PRIVATE LIMITED | $1.4M | 29 | 5 | $50.0K |
| 7 | MANEESH PHARMACEUTICALS LTD ★ | $850.0K | 17 | 7 | $50.0K |
| 10 | COMBITIC GLOBAL CAPLET PRIVATE LIMITED | $803.7K | 24 | 2 | $33.5K |
| 9 | MEDWISE OVERSEAS PRIVATE LIMITED | $750.0K | 15 | 4 | $50.0K |
Maneesh Pharmaceuticals Ltd ranks #7 among 175 Indian Rifampicin exporters. Average shipment value of $50.0K compared to the market average of $696.0K. The closest competitors by value are SANDOZ PRIVATE LIMITED and OMNICALS PHARMA PRIVATE LIMITED.
Which Indian Ports Ship Rifampicin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 947 | 24.2% |
| SAHAR AIR | 813 | 20.8% |
| DELHI AIR CARGO ACC (INDEL4) | 477 | 12.2% |
| DELHI AIR | 404 | 10.3% |
| NHAVA SHEVA SEA (INNSA1) | 295 | 7.5% |
| Bombay Air | 175 | 4.5% |
| JNPT/ NHAVA SHEVA SEA | 116 | 3.0% |
| JNPT | 99 | 2.5% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rifampicin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rifampicin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Maneesh Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 224 individual customs records matching Maneesh Pharmaceuticals Ltd exporting Rifampicin, covering 121 formulations to 44 countries via 74 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 162+ countries, 780+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rifampicin Export Data from Maneesh Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Maneesh Pharmaceuticals Ltd's Rifampicin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Maneesh Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Rifampicin Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Maneesh Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rifampicin. For current shipment-level data, contact TransData Nexus.